Graphene Oxide-Based Highly Sensitive Assay of Circulating MicroRNAs for Early Prediction of the Response to Neoadjuvant Chemotherapy in Breast Cancer-Reference-Cited by-同舟云学术

Graphene Oxide-Based Highly Sensitive Assay of Circulating MicroRNAs for Early Prediction of the Response to Neoadjuvant Chemotherapy in Breast Cancer

Published:2022-11-07 Issue:46 Volume:94 Page:16254-16264
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Li Zhijia¹,Xiao Hongtao²,Li Junjie²,Yang Zhongzhu¹,Jiang Jun²,Ji Juan²,Peng Cheng¹,He Yang¹^ORCID

Affiliation:

1. State Key Laboratory of Southwestern Chinese Medicine Resources, College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China

2. Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital affiliated to School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China

Funder

State Administration of Traditional Chinese Medicine of the People's Republic of China

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.2c04117

Reference45 articles.

1. Cancer statistics in China, 2015

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials